会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • FACTOR TAKING PART IN TRANSCRIPTION CONTROL
    • 收购控制部分的因素
    • US20120088301A1
    • 2012-04-12
    • US13296878
    • 2011-11-15
    • Shuki MIZUTANITakayuki Yamada
    • Shuki MIZUTANITakayuki Yamada
    • C12N5/10C12N15/85C12N15/11
    • C07K14/4702
    • HDART binds with HDAC (histone deacetylase) and function as a repressor. HDART directly binds with Skip functioning as a transcription co-activator of a nuclear receptor to repress the transcription of the nuclear receptor. Moreover, HDART is one of transcription co-repressors of nuclear receptor, and binds with HDAC thereby enabling intense repression of transcription through the histone deacetylization of HDAC. On the other hand, a dominant negative peptide of HDART can be obtained, and it has been confirmed that this peptide activates transcription contrary to the HDART protein of the full length. Especially, the transcription activity of retinoic acid receptor with this peptide has an activity exceeding all-trans retinoic acid (ATRA).
    • HDART与HDAC(组蛋白脱乙酰酶)结合并作为阻遏物起作用。 HDART直接与Skip发挥作用,作为核受体的转录共激活剂,以抑制核受体的转录。 此外,HDART是核受体的转录共抑制因子之一,并与HDAC结合,从而通过HDAC的组蛋白脱乙酰化使得能够强烈抑制转录。 另一方面,可以获得HDART的显性负性肽,并且已经证实该肽激活与全长的HDART蛋白相反的转录。 特别地,视黄酸受体与该肽的转录活性具有超过全反式视黄酸(ATRA)的活性。